New Twists for the AWP/First Databank Settlement
June 17, 2008
Drug database firm to pay $1 million to settle price-fixing suit | www.mercurynews.com
Average Wholesale Price (AWP) data for pharmaceuticals is still being published, but will continue to lose appeal as a reimbursement benchmark for pharmacies and Pharmacy benefit managers (PBMs). The latest amended (and still unapproved) settlement does not require First Databank to stop publishing AWP or roll back AWP on all drugs. Nonetheless, First Databank has announced that it will unilaterally roll back the AWP for all drugs to 1.20 and discontinue publishing the Blue Book AWP data independent of the litigation. So the outcome would be the same (no more published AWP) although the currently proposed settlement does not technically require the demise of AWP.
Cardinal Health Apologizes To Customers
June 6, 2008
An Open Letter to Our Customers | www.cardinal.com
Cardinal Health (CAH) has recently started publicizing An Open Letter to Our Customers from Chairman and CEO Kerry Clark. Cardinal is still struggling to balance their enforcement responsibilities with the legitimate needs of pharmacies and patients. While Cardinal desperately needs to resolve its DEA issues, I think that the company still has an opportunity to recover from its missteps and regain some lost market share.
CA Sets More Realistic Pedigree Deadline, but Timeline Still Uncertain
June 5, 2008
Legislation seeks to ensure safety of all prescription drugs | dist26.casen.govoffice.com
California State Senator Ridley-Thomas has proposed further extensions of the deadline for serialization for pharmaceutical manufacturers. I’m encouraged that California will be incorporating more realistic timelines for serialization, especially given the unknown prospects for national standards. However, it's harder than ever to predict the precise future deadlines that manufacturers, wholesalers, and pharmacies will face.
NABP Exposes Fake Candian Online Pharmacies
June 2, 2008
NABP Names 79 Internet Drug Outlets Operating in Conflict With Patient Safety and Pharmacy Practice Standards | news.yahoo.com
The National Association of Boards of Pharmacy (NABP) named 79 online pharmacies that are not safe for patients. Rather than a general “watch out” message, the NABP actually listed the web addresses for these rogue sources. Many sites falsely claim to be “Canadian” pharmacies. This was an important step, but much work remains to convince consumers about the dangers of online pharmacies. Presidential candidate John McCain is also supports importation, but NABP’s warning should make him reconsider.
More Trouble for Cardinal Health
June 2, 2008
State investigating Cardinal | dispatch.com
A fifth Cardinal Health (CAH) location is now under investigation for allegedly failing to report “suspicious orders” of controlled substances from its Findlay, OH, warehouse. Cardinal Health has requested a hearing before the pharmacy board, so I presume nothing will happen until then. Penalties could range from a fine (most likely, IMHO) to revocation of its wholesale license (improbable but possible).
Chinese generics is nothing new
May 21, 2008
China Muscles In On The Generics Industry | www.pharmalot.com
In 1976, sitting in my office in International Marketing at Fisons, Loughborough, UK, I used to watch the drums of bulk paracetamol arriving at the factory from China - easily recognizable from the Chinese script decorating them. I'm sure the UK wasn't the only country importing raw materials from China then.
Reverse Payments for PHRMA smell fishy
May 15, 2008
US trade agency wants to end deals delaying generics | www.reuters.com
Our FTC has gone on record once again stating that the so called "Phrma reverse payments" to generic manufacturers breach antitrust regulations. Delaying competition by simply paying off another supplier, leads to higher prices for me, you, and our families. My grandpa used to call this stuff by another term....."shmearing".
Neuronal nicotinic receptor agonists potential breakthrough for ADHD research
May 12, 2008
Abbott Scientists Present A New Approach for Treating Attention-Deficit Hyperactivity Disorder | biz.yahoo.com
1. Effective treatment for ADHD 2. Well tolerated with few side effects 3. Help with smoking, a big problem in ADHD patients important 4. Advantage in not being Schedule II may be helpful
Important New Data for Children and Adolescents
May 12, 2008
FDA Approves Strattera® for Maintenance of ADHD in Children and Adolescents | newsroom.lilly.com
1. Important new finding given safety concerns raised about this and other treatmetns 2. Nice to have data back up what has long been done clinically 3. Stimulants still first line and lack of active comparator trial
Analysis of Wal-Mart's Generics Plan
May 8, 2008
Wal-Mart expands low-price drug program | ap.google.com
Wal-Mart Stores (WMT) latest expansion of its generic drug program represents more of the same despite the company's promise on Friday to make a “major health care announcement.” Nonetheless, the company’s latest comments shed additional light on the true economics of the program. Here are some high level points about Wal-Mart’s generic program.
What is potential future for Sequenom in prenatal testing.
November 9, 2009
November 7, 2009
Express Scripts feeling Growing Pains
October 29, 2009
CDC Outlines H1N1 Test Guidelines
October 8, 2009
Why Health Care Costs Keep Rising—And What to Do About It
September 13, 2009